The Intestinal Gas Questionnaire (IGQ): Psychometric validation of a new instrument for measuring gas-related symptoms and their impact on daily life among general population and irritable bowel syndrome

被引:6
作者
Duracinsky, Martin [1 ,2 ]
Archbold, Sharon [3 ]
Lobo, Beatriz [4 ,5 ,6 ,7 ]
Bessonneau, Pascal [1 ]
Thonon, Frederique [1 ]
Santos, Javier [4 ,5 ,6 ,7 ]
Guagnozzi, Danila [4 ,5 ,6 ,7 ]
Payakachat, Nalin [8 ]
Coffin, Benoit [9 ]
Azpiroz, Fernando [4 ,5 ,6 ,7 ]
Whorwell, Peter J. [3 ]
Chassany, Olivier [1 ,2 ]
机构
[1] Paris Diderot Univ, Patient Ctr Reported Outcomes, Paris, France
[2] Hop Hotel Dieu, AP HP, Hlth Econ Clin Trial Unit URC ECO, Paris, France
[3] Univ Manchester, Wythenshawe Hosp, Fac Biol Med & Hlth, Sch Med Sci,Neurogastroenterol Unit, Manchester, Lancs, England
[4] Vall Hebron Inst Recerca VHIR, Digest Syst Res Unit, Unitat Fisiol & Fisiopatol Digest, Barcelona, Spain
[5] Vall Hebron Hosp Univ, Serv Aparell Digestiu, Vall Hebron Barcelona Hosp Campus, Barcelona, Spain
[6] Inst Salud Carlos III, CIBER Enfermedades Hepat & Digest CIBERHED, Madrid, Spain
[7] Univ Autonoma Barcelona, Fac Med, Bellaterra, Spain
[8] Univ Arkansas Med Sci, Dept Pharm Practice, Coll Pharm, Little Rock, AR USA
[9] Louis Mourier Hosp, AP HP, Gastroenterol Dept, Colombes, France
关键词
gas-related symptoms; general population; IBS; patient-reported outcomes; psychometrics; quality of life; QUALITY-OF-LIFE; DIGESTIVE SYMPTOMS; FERMENTED MILK; DOUBLE-BLIND; DISTENSION; EQUIVALENCE; PREVALENCE; ADULTS;
D O I
10.1111/nmo.14202
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Gas-related symptoms (GRS) are common in the general population (GPop) and among patients with disorders of gut-brain interactions but there is no patient-reported outcome evaluating these symptoms and their impact on daily life. We have previously developed a 43-item intestinal gas questionnaire (IGQ). The aim of the present study is to perform a psychometric validation of this instrument. Methods Participants (119 from the GPop and 186 irritable bowel syndrome (IBS) patients) were recruited from 3 countries (UK, Spain, France). IBS patients fulfilled ROME IV criteria with an IBS severity score between 150 and 300. Participants completed the IGQ, the functional Digestive Disorders Quality of Life (FDDQL), and the EQ-5D. A subgroup (n = 90) repeated the IGQ completion after 7 days on paper or electronically. Results From the original IGQ questionnaire, 26 items were deleted because of poor performance. Confirmatory factorial analysis on the remaining 17 items (7 symptom and 10 impact items) yielded a 6-factor structure accounting for 67% of the variance for bloating (6 items), flatulence (3), belching (2), bad breath (2), stomach rumbling (2), and difficult gas evacuation (2). Global score (0-100) was worse among IBS vs GPop (40 +/- 15 vs 33 +/- 17; p = 0.0016). At the second visit, the intraclass correlation coefficient of IGQ scores was between 0.71 and 0.86 (n = 67) for test-retest reliability and 0.61-0.87 (n = 64) for equivalence between electronic and paper versions of IGQ. Conclusion The IGQ available in paper and electronic versions in 3 languages is a robust instrument for capturing and measuring GRS and their impact on daily life.
引用
收藏
页数:14
相关论文
共 44 条
[41]   Perceptions of flatulence from bean consumption among adults in 3 feeding studies [J].
Winham, Donna M. ;
Hutchins, Andrea M. .
NUTRITION JOURNAL, 2011, 10
[42]   Practical issues encountered while determining Minimal Clinically Important Difference in Patient-Reported Outcomes [J].
Woaye-Hune, Pascal ;
Hardouin, Jean-Benoit ;
Lehur, Paul-Antoine ;
Meurette, Guillaume ;
Vanier, Antoine .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2020, 18 (01)
[43]   Measuring Diet Intake and Gastrointestinal Symptoms in Irritable Bowel Syndrome: Validation of the Food and Symptom Times Diary [J].
Wright-McNaughton, Morag ;
Huinink, Sebastiaan ten Bokkel ;
Frampton, Christopher M. A. ;
McCombie, Andrew M. ;
Talley, Nicholas J. ;
Skidmore, Paula M. L. ;
Gearry, Richard B. .
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2019, 10 :e00103
[44]  
Wyrwich Kathleen W, 2004, J Biopharm Stat, V14, P97, DOI 10.1081/BIP-120028508